Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study.
Journal
The Lancet. Global health
ISSN: 2214-109X
Titre abrégé: Lancet Glob Health
Pays: England
ID NLM: 101613665
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
16
09
2019
revised:
05
12
2019
accepted:
13
12
2019
pubmed:
24
2
2020
medline:
2
7
2020
entrez:
24
2
2020
Statut:
ppublish
Résumé
Seasonal influenza virus is a common cause of acute lower respiratory infection (ALRI) in young children. In 2008, we estimated that 20 million influenza-virus-associated ALRI and 1 million influenza-virus-associated severe ALRI occurred in children under 5 years globally. Despite this substantial burden, only a few low-income and middle-income countries have adopted routine influenza vaccination policies for children and, where present, these have achieved only low or unknown levels of vaccine uptake. Moreover, the influenza burden might have changed due to the emergence and circulation of influenza A/H1N1pdm09. We aimed to incorporate new data to update estimates of the global number of cases, hospital admissions, and mortality from influenza-virus-associated respiratory infections in children under 5 years in 2018. We estimated the regional and global burden of influenza-associated respiratory infections in children under 5 years from a systematic review of 100 studies published between Jan 1, 1995, and Dec 31, 2018, and a further 57 high-quality unpublished studies. We adapted the Newcastle-Ottawa Scale to assess the risk of bias. We estimated incidence and hospitalisation rates of influenza-virus-associated respiratory infections by severity, case ascertainment, region, and age. We estimated in-hospital deaths from influenza virus ALRI by combining hospital admissions and in-hospital case-fatality ratios of influenza virus ALRI. We estimated the upper bound of influenza virus-associated ALRI deaths based on the number of in-hospital deaths, US paediatric influenza-associated death data, and population-based childhood all-cause pneumonia mortality data in six sites in low-income and lower-middle-income countries. In 2018, among children under 5 years globally, there were an estimated 109·5 million influenza virus episodes (uncertainty range [UR] 63·1-190·6), 10·1 million influenza-virus-associated ALRI cases (6·8-15·1); 870 000 influenza-virus-associated ALRI hospital admissions (543 000-1 415 000), 15 300 in-hospital deaths (5800-43 800), and up to 34 800 (13 200-97 200) overall influenza-virus-associated ALRI deaths. Influenza virus accounted for 7% of ALRI cases, 5% of ALRI hospital admissions, and 4% of ALRI deaths in children under 5 years. About 23% of the hospital admissions and 36% of the in-hospital deaths were in infants under 6 months. About 82% of the in-hospital deaths occurred in low-income and lower-middle-income countries. A large proportion of the influenza-associated burden occurs among young infants and in low-income and lower middle-income countries. Our findings provide new and important evidence for maternal and paediatric influenza immunisation, and should inform future immunisation policy particularly in low-income and middle-income countries. WHO; Bill & Melinda Gates Foundation.
Sections du résumé
BACKGROUND
Seasonal influenza virus is a common cause of acute lower respiratory infection (ALRI) in young children. In 2008, we estimated that 20 million influenza-virus-associated ALRI and 1 million influenza-virus-associated severe ALRI occurred in children under 5 years globally. Despite this substantial burden, only a few low-income and middle-income countries have adopted routine influenza vaccination policies for children and, where present, these have achieved only low or unknown levels of vaccine uptake. Moreover, the influenza burden might have changed due to the emergence and circulation of influenza A/H1N1pdm09. We aimed to incorporate new data to update estimates of the global number of cases, hospital admissions, and mortality from influenza-virus-associated respiratory infections in children under 5 years in 2018.
METHODS
We estimated the regional and global burden of influenza-associated respiratory infections in children under 5 years from a systematic review of 100 studies published between Jan 1, 1995, and Dec 31, 2018, and a further 57 high-quality unpublished studies. We adapted the Newcastle-Ottawa Scale to assess the risk of bias. We estimated incidence and hospitalisation rates of influenza-virus-associated respiratory infections by severity, case ascertainment, region, and age. We estimated in-hospital deaths from influenza virus ALRI by combining hospital admissions and in-hospital case-fatality ratios of influenza virus ALRI. We estimated the upper bound of influenza virus-associated ALRI deaths based on the number of in-hospital deaths, US paediatric influenza-associated death data, and population-based childhood all-cause pneumonia mortality data in six sites in low-income and lower-middle-income countries.
FINDINGS
In 2018, among children under 5 years globally, there were an estimated 109·5 million influenza virus episodes (uncertainty range [UR] 63·1-190·6), 10·1 million influenza-virus-associated ALRI cases (6·8-15·1); 870 000 influenza-virus-associated ALRI hospital admissions (543 000-1 415 000), 15 300 in-hospital deaths (5800-43 800), and up to 34 800 (13 200-97 200) overall influenza-virus-associated ALRI deaths. Influenza virus accounted for 7% of ALRI cases, 5% of ALRI hospital admissions, and 4% of ALRI deaths in children under 5 years. About 23% of the hospital admissions and 36% of the in-hospital deaths were in infants under 6 months. About 82% of the in-hospital deaths occurred in low-income and lower-middle-income countries.
INTERPRETATION
A large proportion of the influenza-associated burden occurs among young infants and in low-income and lower middle-income countries. Our findings provide new and important evidence for maternal and paediatric influenza immunisation, and should inform future immunisation policy particularly in low-income and middle-income countries.
FUNDING
WHO; Bill & Melinda Gates Foundation.
Identifiants
pubmed: 32087815
pii: S2214-109X(19)30545-5
doi: 10.1016/S2214-109X(19)30545-5
pmc: PMC7083228
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e497-e510Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : CGH CDC HHS
ID : U01 GH001003
Pays : United States
Investigateurs
Harish Nair
(H)
Harry Campbell
(H)
Xin Wang
(X)
You Li
(Y)
Alexandria Chung
(A)
Manveer Rahi
(M)
Qalab Abbas
(Q)
Asad Ali
(A)
Zulfiqar A Bhutta
(ZA)
Bushra Saeed
(B)
Sajid B Soofi
(SB)
Mohammad Tahir Yousafzai
(MT)
Anita K Zaidi
(AK)
Alberta Amu
(A)
Elizabeth Awini
(E)
Eduardo Azziz-Baumgartner
(E)
Henry C Baggett
(HC)
Sandra S Chaves
(SS)
Nong Shang
(N)
Stephanie J Schrag
(SJ)
Marc-Alain Widdowson
(MA)
Stefano Tempia
(S)
Quique Bassat
(Q)
Miguel Lanaspa
(M)
Sozinho Acácio
(S)
W Abdullah Brooks
(WA)
Amanda Driscoll
(A)
Maria Deloria Knoll
(MD)
Katherine L O'Brien
(KL)
Christine Prosperi
(C)
Abdullah H Baqui
(AH)
Luke Mullany
(L)
Peter Byass
(P)
Cheryl Cohen
(C)
Anne von Gottberg
(A)
Orienka Hellferscee
(O)
Florette K Treurnicht
(FK)
Sibongile Walaza
(S)
Doli Goswami
(D)
Mustafizur Rahman
(M)
Nicholas E Connor
(NE)
Shams El Arifeen
(S)
Marcela Echavarria
(M)
Débora N Marcone
(DN)
Noelia Reyes
(N)
Andrea Gutierrez
(A)
Ivan Rodriguez
(I)
Olga Lopez
(O)
David Ortiz
(D)
Nathaly Gonzalez
(N)
Angela Gentile
(A)
Maria Del Valle Juarez
(M)
Aubree Gordon
(A)
Clare Cutland
(C)
Michelle Groome
(M)
Shabir A Madhi
(SA)
Marta C Nunes
(MC)
Susan Nzenze
(S)
Terho Heikkinen
(T)
Siddhivinayak Hirve
(S)
Sanjay Juvekar
(S)
Natasha Halasa
(N)
Jorge H Jara
(JH)
Chris Bernart
(C)
Mark A Katz
(MA)
Ilan Gofer
(I)
Yonat Shemer Avni
(YS)
Najwa Khuri-Bulos
(N)
Samir Faori
(S)
Asem Shehabi
(A)
Anand Krishnan
(A)
Rakesh Kumar
(R)
Ritvik Amarchand
(R)
Carmen L Contreras
(CL)
Oscar de Leon
(O)
Maria R Lopez
(MR)
John P McCracken
(JP)
Herberth Maldonado
(H)
Antonio P Samayoa
(AP)
Ana B Gomez
(AB)
Marilla G Lucero
(MG)
Leilani T Nillos
(LT)
Socorro P Lupisan
(SP)
Hanna Nohynek
(H)
Ainara Mira-Iglesias
(A)
Joan Puig-Barberà
(J)
Javier Díez-Domingo
(J)
Bradford D Gessner
(BD)
Berthe-Marie Njanpop-Lafourcade
(BM)
Jennifer C Moïsi
(JC)
Haoua Tall
(H)
Patrick K Munywoki
(PK)
Mwanjuma Ngama
(M)
D James Nokes
(DJ)
Saad B Omer
(SB)
Dayna R Clark
(DR)
Millogo Ourohiré
(M)
Sié Ali
(S)
Zabré Pascal
(Z)
Bagagnan H Cheik
(BH)
Mauricio T Caballero
(MT)
Romina Libster
(R)
Fernando P Polack
(FP)
Zeba A Rasmussen
(ZA)
Elizabeth D Thomas
(ED)
Julia M Baker
(JM)
Barbara A Rath
(BA)
Patrick E Obermeier
(PE)
M D Hassanuzzaman
(MD)
Maksuda Islam
(M)
Mohammad S Islam
(MS)
Samir K Saha
(SK)
Pinaki Panigrahi
(P)
Anuradha Bose
(A)
Rita Isaac
(R)
David Murdoch
(D)
Pritish Nanda
(P)
Shamim A Qazi
(SA)
Danielle Hessong
(D)
Eric Af Simőes
(EA)
Viviana Sotomayor
(V)
Somsak Thamthitiwat
(S)
Malinee Chittaganpitch
(M)
Halima Dawood
(H)
Catherine Kyobutungi
(C)
Marylene Wamukoya
(M)
Abdhalah K Ziraba
(AK)
Lay-Myint Yoshida
(LM)
Keisuke Yoshihara
(K)
Duc-Anh Dand
(DA)
Minh-Nhat Le
(MN)
Mark P Nicol
(MP)
Heather J Zar
(HJ)
Shobha Broor
(S)
Mandeep Chadha
(M)
Lola Madrid
(L)
Lionel Gresh
(L)
Angel Balmaseda
(A)
Guillermina Kuan
(G)
Niteen Wairagkar
(N)
Milagritos D Tapia
(MD)
Stacey L Knobler
(SL)
Alfredo Barahona
(A)
Ericka Ferguson
(E)
Brunhilde Schweiger
(B)
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Références
MMWR Surveill Summ. 2013 Oct 25;62(4):1-28
pubmed: 24157710
Influenza Other Respir Viruses. 2013 Sep;7 Suppl 2:105-13
pubmed: 24034494
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S66-S75
pubmed: 28398999
Influenza Other Respir Viruses. 2015 Mar;9(2):85-93
pubmed: 25557920
Western Pac Surveill Response J. 2013 Mar 03;4(3):51-9
pubmed: 24319615
Vaccine. 2016 Oct 26;34(45):5400-5405
pubmed: 27646030
Lancet Respir Med. 2014 Sep;2(9):750-63
pubmed: 25131494
Clin Infect Dis. 2019 Nov 13;69(11):1845-1853
pubmed: 30715278
Am J Epidemiol. 2018 Feb 1;187(2):378-388
pubmed: 28679157
J Glob Health. 2015 Jun;5(1):010408
pubmed: 26445672
Pediatr Infect Dis J. 2018 May;37(5):436-440
pubmed: 29443825
Lancet Glob Health. 2018 Dec;6(12):e1268-e1269
pubmed: 30420025
PLoS One. 2015 Apr 20;10(4):e0126997
pubmed: 25894233
Sci Transl Med. 2013 Jun 26;5(191):191ra84
pubmed: 23803706
Lancet. 2011 Dec 3;378(9807):1917-30
pubmed: 22078723
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Int J Epidemiol. 2012 Jun;41(3):579-88
pubmed: 22798690
Nat Med. 2004 Aug;10(8):811-3
pubmed: 15247911
Vaccine. 2017 Aug 24;35(36):4681-4686
pubmed: 28754488
Lancet Glob Health. 2019 Jan;7(1):e47-e57
pubmed: 30497986
Lancet. 2013 Apr 20;381(9875):1380-1390
pubmed: 23369797
Lancet. 2016 Dec 10;388(10062):e19-e23
pubmed: 27371184
Vaccine. 2009 Aug 21;27 Suppl 3:C9-C14
pubmed: 19683658
Lancet. 2017 Sep 2;390(10098):946-958
pubmed: 28689664
Pediatr Infect Dis J. 2015 Jan;34(1):66-72
pubmed: 25093972
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
PLoS Med. 2016 Mar 24;13(3):e1001977
pubmed: 27011229
Lancet Respir Med. 2019 Jan;7(1):69-89
pubmed: 30553848
Clin Infect Dis. 2018 Jan 6;66(1):95-103
pubmed: 29040527
Croat Med J. 2013 Apr;54(2):122-34
pubmed: 23630140
Clin Infect Dis. 2017 Oct 1;65(7):1066-1071
pubmed: 28575286
JAMA Pediatr. 2016 Sep 1;170(9):840-7
pubmed: 27380464
Lancet Infect Dis. 2016 Sep;16(9):1026-1035
pubmed: 27261067
Hum Vaccin Immunother. 2016 Aug 2;12(8):2206-2214
pubmed: 27196006
Influenza Other Respir Viruses. 2016 Jul;10(4):254-67
pubmed: 26842617
Stat Med. 2010 Dec 20;29(29):3046-67
pubmed: 20827667
Vaccine. 2018 Jan 25;36(4):442-452
pubmed: 29287683
Vaccine. 2014 Nov 12;32(48):6369-76
pubmed: 25442403